Case Study: medmix cuts third-party review time by 97% with GAN Integrity

medmix cuts third-party review time by 97% with GAN Integrity

medmix, a Swiss-based global manufacturer of high-precision delivery devices, faced a significant compliance challenge after its IPO and separation from its parent company. The company inherited fragmented, non-scalable tools across its eight global locations, which made obtaining a clear view of third-party risk slow and board reporting entirely manual. To address this, medmix partnered with GAN Integrity to implement its integrated compliance platform.

GAN Integrity provided a single platform that consolidated third-party due diligence, whistleblowing, investigations, policies, and training. The solution was tailored to medmix's specific risk profile and governance structure, enabling a rapid deployment. The results were transformative, yielding a 97% reduction in third-party review cycle time, with low-risk parties now screened in minutes. This provided global visibility, automated board reporting, and allowed the lean compliance team to focus on high-risk cases that require human judgment.

MEDMIX